Antiepileptic drugs and brain development

被引：112

作者：

Ikonomidou, Chrysanthy ^{[1
,3
]}

Turski, Lechoslaw ^{[2
]}

机构：

[1] Univ Wisconsin, Waisman Ctr, Madison, WI 53792 USA

[2] Solvay Pharmaceut Res Labs, NL-1381 CP Weesp, Netherlands

[3] Univ Wisconsin, Dept Neurol, Madison, WI 53792 USA

来源：

EPILEPSY RESEARCH | 2010年 / 88卷 / 01期

关键词：

Development; Apoptosis; Neurodegeneration; Neurogenesis; Synaptogenesis; Anticonvulsants; DEVELOPING RAT-BRAIN; PRENATAL PHENYTOIN EXPOSURE; NERVOUS-SYSTEM DEVELOPMENT; FETAL HYDANTOIN SYNDROME; INDUCED BIRTH-DEFECTS; SPINAL-CORD NEURONS; VALPROIC ACID; APOPTOTIC NEURODEGENERATION; CELL-DEATH; GRANULE CELLS;

D O I：

10.1016/j.eplepsyres.2009.09.019

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Epilepsy, the most common neurological disorder in young humans, has its highest incidence during the first year of life. Antiepileptic drugs (AEDs) which are used to treat seizures in infants, children and pregnant women target ion channels, neurotransmitters and second messenger systems in the brain. The same targets regulate brain processes essential both for propagation of seizures and for brain development, learning, memory and emotional behavior. Here we review adverse effects of AEDs in the developing mammalian brain. In addition, we discuss mechanisms explaining adverse effects of AEDs in the developing mammalian brain including interference with cell proliferation and migration, neurogenesis, axonal. arborization, synaptogenesis, synaptic plasticity and physiological apoptotic cell death. (C) 2009 Elsevier B.V. All rights reserved.

引用

页码：11 / 22

页数：12

共 112 条

[1] Protection with estradiol in developmental models of apoptotic neurodegeneration [J].

Asimiadou, S ;

Bittigau, P ;

Felderhoff-Mueser, U ;

Manthey, D ;

Sifringer, M ;

Pesditschek, S ;

Dzietko, M ;

Kaindl, AM ;

Pytel, M ;

Studniarczyk, D ;

Mozrzymas, JW ;

Ikonomidou, C .

ANNALS OF NEUROLOGY, 2005, 58 (02) :266-276

[2] INDUCTION OF LTP IN THE HIPPOCAMPUS NEEDS SYNAPTIC ACTIVATION OF GLUTAMATE METABOTROPIC RECEPTORS [J].

BASHIR, ZI ;

BORTOLOTTO, ZA ;

DAVIES, CH ;

BERRETTA, N ;

IRVING, AJ ;

SEAL, AJ ;

HENLEY, JM ;

JANE, DE ;

WATKINS, JC ;

COLLINGRIDGE, GL .

NATURE, 1993, 363 (6427) :347-350

[3]

BAYER SA, 1993, NEUROTOXICOLOGY, V14, P83

[4] ADVERSE-EFFECTS OF PHENOBARBITAL ON MORPHOLOGICAL AND BIOCHEMICAL DEVELOPMENT OF FETAL MOUSE SPINAL-CORD NEURONS IN CULTURE [J].

BERGEY, GK ;

SWAIMAN, KF ;

SCHRIER, BK ;

FITZGERALD, S ;

NELSON, PG .

ANNALS OF NEUROLOGY, 1981, 9 (06) :584-589

[5]

BERGMAN A, 1982, ACTA ANAT, V114, P185

[6] SELECTIVE CHANGES IN MOUSE BEHAVIORAL-DEVELOPMENT AFTER PRENATAL BENZODIAZEPINE EXPOSURE - A PROGRESS REPORT [J].

BIGNAMI, G ;

ALLEVA, E ;

CHIAROTTI, F ;

LAVIOLA, G .

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1992, 16 (05) :587-604

[7] Antiepileptic drugs and apoptotic neurodegeneration in the developing brain [J].

Bittigau, P ;

Sifringer, M ;

Genz, K ;

Reith, E ;

Pospischil, D ;

Govindarajalu, S ;

Dzietko, M ;

Pesditschek, S ;

Mai, I ;

Dikranian, K ;

Olney, JW ;

Ikonomidou, C .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (23) :15089-15094

[8] PHENYTOIN NEUROTOXICITY IN DEVELOPING MOUSE CEREBELLUM IN TISSUE-CULTURE [J].

BLANK, NK ;

NISHIMURA, RN ;

SEIL, FJ .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 1982, 55 (01) :91-97

[9] Comparison of valproate and phenobarbital treatment after status epilepticus in rats [J].

Bolanos, AR ;

Sarkisian, M ;

Yang, Y ;

Hori, A ;

Helmers, SL ;

Mikati, M ;

Tandon, P ;

Stafstrom, CE ;

Holmes, GL .

NEUROLOGY, 1998, 51 (01) :41-48

[10]

Brooks WJ, 1997, SYNAPSE, V26, P104

← 1 2 3 4 5 6 7 8 9 10 →